Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL
Novartis
Novartis
Adicet Therapeutics
Genmab
Genmab
Genmab
Genmab
Genmab
Genmab
Hoffmann-La Roche
Seagen Inc.
Incyte Corporation
Pfizer
Acerta Pharma BV
Pfizer
ADC Therapeutics S.A.
Cellectar Biosciences, Inc.
Seagen Inc.
Galapagos NV
BeOne Medicines
Dizal Pharmaceuticals
Monte Rosa Therapeutics, Inc
Merck Sharp & Dohme LLC
Tanabe Pharma Corporation
Hoffmann-La Roche
Regeneron Pharmaceuticals
Hoffmann-La Roche
Incyte Corporation
Miltenyi Biomedicine GmbH
Incyte Corporation
Incyte Corporation
Sana Biotechnology
Immunitas Therapeutics
Regeneron Pharmaceuticals
Bristol-Myers Squibb
Sana Biotechnology
Sichuan Baili Pharmaceutical Co., Ltd.
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Hutchmed
Genmab
Synthekine
Shanghai Ming Ju Biotechnology Co., Ltd.
Genmab
Genmab
Cothera Bioscience, Inc
Shanghai Blueray Biopharma Co., Ltd.
Tessa Therapeutics